Page last updated: 2024-08-24

capecitabine and Epistaxis

capecitabine has been researched along with Epistaxis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huo, B; Lin, L; Yang, J; Yu, R; Zhao, L	1

Other Studies

1 other study(ies) available for capecitabine and Epistaxis

Article	Year
First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab. Renal failure, 2023, Volume: 45, Issue:2 Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Capecitabine; Epistaxis; Humans; Kidney Diseases; Lung Diseases; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Oxaliplatin; Peroxidase; Trastuzumab	2023

Article

Year

First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab.

Renal failure, 2023, Volume: 45, Issue:2

Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Capecitabine; Epistaxis; Humans; Kidney Diseases; Lung Diseases; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Oxaliplatin; Peroxidase; Trastuzumab

2023